Metastatic Colorectal Cancer With RAS Mutation
1 clinical trials · Condition
◉ Watch Metastatic Colorectal Cancer With RAS Mutation
| Record | Firm | Date |
|---|---|---|
| XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation (NCT06936527) | NovaOnco Therapeutics Co., Ltd. | 2025-05-23 |
Track Metastatic Colorectal Cancer With RAS Mutation automatically
Every clearance here is in the API, with alerts when new ones post.